The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
MOMENTUM
Recruiting
8,000 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
DP-04
Recruiting
100 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
GUARDIAN-101
Phase 1 Recruiting
90 enrolled
EXCEED
Phase 1 Recruiting
490 enrolled
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
216 enrolled
BCB RIV
Phase NA Recruiting
350 enrolled
PharmTRT
Recruiting
600 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 Recruiting
740 enrolled
iCaRe2
Recruiting
999,999 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
51 enrolled
TAGNOT
Phase 1/2 Recruiting
58 enrolled
CAMPERR
Recruiting
7,000 enrolled
P-MRI
Recruiting
950 enrolled
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
145 enrolled
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Phase 1/2 Recruiting
27 enrolled
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Phase 1/2 Recruiting
862 enrolled
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Phase NA Recruiting
40 enrolled
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Phase 1/2 Recruiting
126 enrolled
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Phase 1 Recruiting
30 enrolled
FASCINATE
Phase NA Recruiting
100 enrolled
JUMP
Phase NA Recruiting
86 enrolled
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
115 enrolled
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Recruiting
5,000 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
Phase NA Recruiting
150 enrolled
MOHCCN-O
Recruiting
500 enrolled
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
Phase 1/2 Recruiting
71 enrolled
ReRT
Phase NA Recruiting
1,800 enrolled
COACH
Phase NA Recruiting
625 enrolled
Survivorship
Recruiting
45 enrolled
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Phase 1 Recruiting
33 enrolled
LEARN
Recruiting
300 enrolled
Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient
Recruiting
59 enrolled
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Recruiting
990 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Recruiting
2,700 enrolled
KEYNOTE F19
Phase 1/2 Recruiting
204 enrolled
Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
Recruiting
320 enrolled
ART-02
Recruiting
649 enrolled
ONCOPRO
Phase NA Recruiting
410 enrolled